Furthermore, a similar impact of MRD on PFS and OS was observed when we restricted our analyses to VGPR and CR cases, although the differences did not reach statistical significance, probably due to the small number of patients.
← all excerpts
Lenalidomide Maintenance and Measurable Residual Disease in a Real-World Multiple Myeloma Transplanted Population Receiving Different Treatment Strategies Guided by Access to Novel Drugs in Brazil.
1
—
—